<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158224">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02100293</url>
  </required_header>
  <id_info>
    <org_study_id>B-1307/209-006</org_study_id>
    <nct_id>NCT02100293</nct_id>
  </id_info>
  <brief_title>Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose
      rocuronium, intubation condition and surgical condition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>onset time of rocuronium</measure>
    <time_frame>from injection of rocuronium to T1 suppression more than 95% up to 10 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>from injection of rocuronium to T1 suppression more than 95% up to 10 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>maximal suppression time and duration of rocuronium</measure>
    <time_frame>time from the injection of rocuronium to T1 maximal supression time and reversal of T1 25% up to 1 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>intubation condition</measure>
    <time_frame>intubation condition during induction of anesthesia up to 10 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>We scored intubation condition according to Table 9 of Acta Anaesthesiol Scand 2007;51: 789-808</description>
  </other_outcome>
  <other_outcome>
    <measure>surgical condition</measure>
    <time_frame>intraoperative surgical condition</time_frame>
    <safety_issue>No</safety_issue>
    <description>to score a surgical condition according to 7 point likers scale</description>
  </other_outcome>
  <other_outcome>
    <measure>postoperative sore throat</measure>
    <time_frame>postoperative sore throat up to 4 hours</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Observation of Neuromuscular Block</condition>
  <condition>Intubation Condition</condition>
  <condition>Surgical Condition</condition>
  <arm_group>
    <arm_group_label>standard dose rocuronium group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pretreatment of saline 100ml and rocuronium 0.6 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low dose  rocuronium group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pretreatment of saline 100ml and rocuronium 0.45 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low dose  rocuronium plus magnesium group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pretreatment of magnesium sulfate 30 mg/kg and rocuronium 0.45 mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>magnesium sulfate 30 mg/kg</intervention_name>
    <description>Patients in each group received the magnesium sulfate 30 mg/kg for 2 min in 0.9% normal saline (total volume 100 ml) intravenously for 5 min before induction of anesthesia</description>
    <arm_group_label>low dose  rocuronium plus magnesium group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>Patients in each group received 0.9% normal saline (total volume 100 ml) alone intravenously for 5 min before induction of anesthesia</description>
    <arm_group_label>standard dose rocuronium group</arm_group_label>
    <arm_group_label>low dose  rocuronium group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-75 yr American Society of Anesthesiologists physical status  1 or 2, BMI of
             20-24.9 kg/m2 scheduled for elective laryngeal microsurgery

        Exclusion Criteria:

          -  severe respiratory or cardiac disease hepatic or renal function impairment
             neuromuscular disease on medications affecting neuromuscular function with known
             allergy to the drugs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Hwan Do</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National Univ. Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eunsu Choi, clinical professor</last_name>
    <phone>82317877499</phone>
    <email>potterydoll@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National Univ. Bundang Hospita</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eunsu Choi</last_name>
      <phone>82317877499</phone>
      <email>potterydoll@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 26, 2014</lastchanged_date>
  <firstreceived_date>December 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>magnesium sulfate, rocuronium</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
